Treatment of two children with hereditary tyrosinaemia type I and long-standing renal disease with a 4-hydroxyphenylpyruvate dioxygenase inhibitor (NTBC).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples